Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.99.6 (
sialyltransferase
)
1,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The synthesis of alpha 2,3-linked sialic acid to Gal(beta 1,3)GalNAc is mediated by at least three beta-galactoside alpha 2,3-sialyltransferases (EC 2.4.99.4,
SiaT
-4) that are encoded by three distinct genes. In contrast, only a single gene encodes the beta-galactoside alpha 2,6-sialyltransferase (EC 2.4.99.1,
SiaT
-1). This report assesses the relationship and nature of the
SiaT
-4 genes. Analysis of human-mouse somatic cell hybrids demonstrates that the
sialyltransferase
genes are dispersed in the human genome. The gene for
SiaT
-4 resides in chromosome 8, that for
SiaT
-4b resides in
p21
-p34 of chromosome 1 and that for
SiaT
-4c in q23.3-qter of chromosome 11. The gene symbols for these genes have been designated SIAT4A, SIAT4B and SIAT4C, respectively. To assess the structural organization of one of the
SiaT
-4 genes, a human
SiaT
-4a cDNA from submaxillary glands was isolated and characterized. Rapid amplification of cDNA 5' ends (5'-RACE) analysis indicates an unusually long 1 kb 5'-untranslated leader. The catalytic domain of the cloned sequence was expressed in transfected cells and was shown to be competent in mediating the specific synthesis of sialic acid alpha 2,3 to Gal(beta 1,3)GalNAc-R. Genomic sequences for
SiaT
-4a were also isolated and examined. The data demonstrate that coding information for
SiaT
-4a protein is dispersed into seven discrete exon segments in a manner reminiscent of the
SiaT
-1 gene. Furthermore, as in the
SiaT
-1 gene, intervening sequences interrupt both sialylmotif domains, regions that are conserved among all known sialyltransferases.
...
PMID:Three genes that encode human beta-galactoside alpha 2,3-sialyltransferases. Structural analysis and chromosomal mapping studies. 765 69